Center-Authored Papers

Filters: Author is Meza, Jane  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2012
Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM et al..  2012.  Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(17):2094-101. Abstract
2013
Lao VV, Welcsh P, Luo Y, Carter KT, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ, Loeb LA et al..  2013.  Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.. Translational oncology. 6(4):458-69. Abstract
2014
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Aftercare
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Antineoplastic Combined Chemotherapy Protocols
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
August 2013
Lao VV, Welcsh P, Luo Y, Carter KT, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ, Loeb LA et al..  2013.  Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.. Translational oncology. 6(4):458-69. Abstract
Child
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Child, Preschool
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Clinical Research Division
Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM et al..  2012.  Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(17):2094-101. Abstract
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Lao VV, Welcsh P, Luo Y, Carter KT, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ, Loeb LA et al..  2013.  Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.. Translational oncology. 6(4):458-69. Abstract
Clinical Trials as Topic
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Combined Modality Therapy
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Computer Simulation
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Cost Savings
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Costs and Cost Analysis
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Decision Support Techniques
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Decision Trees
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Diagnostic Imaging
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Granulocyte Colony-Stimulating Factor
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Humans
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Infant
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
July 2014
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
May 2012
Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM et al..  2012.  Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(17):2094-101. Abstract
Monte Carlo Method
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract